Divi's Laboratories Limited Divi's Laboratories Limited

Divi's Laboratories Limited

DIVISLAB

Classifica tra le azioni #910
Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India,... Divi's Laboratories Limited, established in 1990 and based in Hyderabad, India, operates globally in the production and distribution of generic active pharmaceutical ingredients (APIs), intermediate chemicals, and nutraceuticals. The company's market footprint encompasses India, the United States, Asia, Europe, and other international regions. In addition to its core product lines, Divi's offers bespoke synthesis services for APIs and intermediates. It also provides a diverse range of carotenoids and markets various vitamins, catering to the nutritional, pharmaceutical, food and beverage, and animal feed industries. The firm was formerly known as Divi's Research Center before rebranding to Divi's Laboratories Limited in 1994.
Prezzo delle azioni
$100.28
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$26.62B
Variazione (1 giorno)
-0.41%
Variazione (1 anno)
33.45%
Paese
IN
Scambia Divi's Laboratories Limited (DIVISLAB)

Categoria

Healthcare
Ricavi di Divi's Laboratories Limited (DIVISLAB)
Ricavi nel Jun 2026 TTM: $1.24B
Secondo gli ultimi rapporti finanziari di Divi's Laboratories Limited, i ricavi attuali dell'azienda (TTM) sono pari a $1.24B. Nel 2024, l'azienda ha registrato ricavi di $934.96M una diminuzione rispetto a i ricavi dell'anno 2023, che erano pari a $942.90M. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Divi's Laboratories Limited da 2005 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $1.24B 13.27%
2025 $1.09B 17.03%
2024 $934.96M -0.84%
2023 $942.90M -18.66%
2022 $1.16B 23.73%
2021 $936.88M 33.39%
2020 $702.35M 0.99%
2019 $695.47M 16.36%
2018 $597.68M -4.38%
2017 $625.04M 9.65%
2016 $570.02M 14.19%
2015 $499.20M 18.17%
2014 $422.45M 7.02%
2013 $394.74M 7.38%
2012 $367.61M 24.43%
2011 $295.42M 40.91%
2010 $209.66M -9.82%
2009 $232.50M -90.99%
2008 $2.58B 1,444.12%
2007 $167.15M 95.34%
2006 $85.57M 7.56%
2005 $79.55M 0.00%
Ricavi di aziende simili o concorrenti